---
title: "Explainable multimodal speech framework for detecting depression-related signals in Alzheimer's di"
id: "medrxiv-0-an-explainable-multimodal-framework-for-exploring-depression-associated-speech"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-0-an-explainable-multimodal-framework-for-exploring-depression-associated-speech"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.29.26364278v1?rss=1"
published_at: "2026-10-01T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Explainable multimodal speech framework for detecting depression-related signals in Alzheimer's di
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-0-an-explainable-multimodal-framework-for-exploring-depression-associated-speech
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.29.26364278v1?rss=1)
- **Published At:** 2026-10-01T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study explores **depression-associated speech representations** in Alzheimer's disease (AD) using an explainable **multimodal** computational framework that combines linguistic and acoustic features from elicited picture-description speech. - Because the AD cohort lacked directly observed depression labels, the authors applied a source-informed **cross-dataset transfer** approach: a depression-labelled source corpus (DAIC-WOZ) was used to provide affective reference structure while DementiaBank provided the AD speech data. - Unsupervised clustering on the AD speech representations produced two distinct speech sub-phenotypes within the AD cohort; one cluster showed geometric proximity (cosine similarity in a shared latent space) to the depression-labelled source centroid. - The authors emphasise that this proximity is a latent-space geometric similarity and may reflect overlapping domain characteristics as well as affective variance; it does not by itself establish clinical diagnosis. - A proxy supervised classification task used a retained multimodal **ANN** integrating both modalities; this model achieved 92.73% accuracy separating the two unsupervised clusters on an internal hold-out test set, demonstrating the clusters were learnable but not clinically validated. - For interpretability, Shapley Additive exPlanations (**SHAP**) were used to extract feature attributions and to organise influential acoustic and linguistic features into a multimodal taxonomy. - The authors derived a Multimodal SHAP Attribution Magnitude (**MSAM**) score as an exploratory, model-based attribution metric; the MSAM is explicitly not a clinically validated severity measure. - Ethical and data-use details: DAIC-WOZ was accessed under a Data Use Agreement with USC; DementiaBank was accessed via TalkBank protocols. All data were de-identified and no new human participant data were collected. - The work provides an interpretable computational baseline and structural foundation for future prospective validation using independently labelled clinical cohorts; the study does not claim diagnostic validity, longitudinal stability, or clinical validity of the discovered sub-phenotypes.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=bgOmmhmNhkxrPGfznCxPG2QkOKQGTkA8iwkI_2W1EgM-1790894913.2458265-1.2.1.1-xpPc.K2XVnK_Oolo13de3MhOOE4jhFPblij21oNOQcEfw50hPHLhnnXXTRPP7y.c) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.09.29.26364278v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # An explainable multimodal framework for exploring depression-associated speech representations in Alzheimer's disease [ View ORCID Profile](http://orcid.org/0009-0003-7831-7905)Hanein Hassan, Dhruv Patel, Hamza Aagela, Anju Johnson doi: https://doi.org/10.64898/2026.09.29.26364278 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Hanein Hassan University of Huddersfield * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Hanein%2BHassan%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Hassan%20H&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHanein%2BHassan%2B) * [ORCID record for Hanein Hassan](http://orcid.org/0009-0003-7831-7905 "Open in new tab") * For correspondence: hanein.hassan@hud.ac.uk Dhruv Patel University of Huddersfield * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Dhruv%2BPatel%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Patel%20D&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ADhruv%2BPatel%2B) Hamza Aagela University of Huddersfield * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Hamza%2BAagela%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Aagela%20H&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHamza%2BAagela%2B) Anju Johnson University of Huddersfield * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Anju%2BJohnson%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Johnson%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAnju%2BJohnson%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.09.29.26364278v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1311839/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.09.29.26364278v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1311839/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.09.29.26364278v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1311839/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.09.29.26364278v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1311839/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.09.29.26364278v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1311839/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Depression in Alzheimer's disease (AD) is clinically challenging to characterise because affective and cognitive manifestations frequently overlap with the underlying neurodegenerative condition. This study investigates depression-related speech patterns in AD using an explainable multimodal framework that integrates linguistic and acoustic features from elicited picture-description speech. To address the absence of directly observed depression labels in the target AD cohort, we employ a source-informed cross-dataset transfer strategy. Unsupervised clustering identified two distinct speech sub-phenotypes within the AD cohort. By comparing these unsupervised representations to a depression-labelled source corpus, one cluster demonstrated mathematical proximity (measured via cosine similarity in a shared latent space) to the source depression centroid. We explicitly acknowledge that this proximity reflects geometric similarity in a shared latent space, which may encapsulate overlapping domain characteristics alongside affective variance. To validate the structural integrity and separability of these discovered clusters, a proxy supervised classification task was employed. The retained multimodal artificial neural network (ANN) integrated information from both modalities and achieved 92.73\% cluster separability accuracy. This demonstrates that the representation-derived two-cluster partition was highly learnable on the independent internal hold-out test set; it does not establish clinical validity, longitudinal stability, or diagnostic validity of the identified sub-phenotypes. For interpretability, Shapley Additive exPlanations (SHAP) analysis was utilised to extract feature attributions and organise influential acoustic and linguistic features into a multimodal taxonomy. Furthermore, a Multimodal SHAP Attribution Magnitude (MSAM) score was derived as an exploratory model-based attribution score rather than a clinically validated severity measure. Ultimately, this study provides an interpretable computational baseline for characterising depression-related speech variance in AD, establishing a structural foundation for future prospective validation using independently labelled clinical cohorts. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This study constitutes a secondary analysis of existing human speech corpora and was conducted in strict accordance with the data use agreements established by the respective data custodians. The research utilised the DAIC-WOZ dataset, which was accessed following the execution of a formal Data Use Agreement with the University of Southern California. Additionally, the DementiaBank dataset was accessed via the TalkBank repository in compliance with their stipulated protocols for affiliated researchers. The original data collection procedures for both the DAIC-WOZ and DementiaBank corpora were conducted under the ethical oversight of their respective institutional review boards, and informed consent was obtained from all participants by the original investigators. Because this study relies entirely on the retrospective computational analysis of these established, controlled-access datasets, no new primary data involving human participants were collected. All data were processed and stored in strict compliance with the ethical restrictions governing sensitive human speech recordings, and no raw audio data have been deposited in unrestricted public repositories. All datasets used in this study had been de-identified prior to their use in the study. All participants' identities and personally identifiable information were removed or anonymized before the data were accessed and analyzed by the researchers. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability The DAIC-WOZ dataset is available to researchers upon signing a Data Use Agreement via the University of Southern California. DementiaBank is accessible to affiliated researchers via TalkBank. Due to ethical restrictions regarding sensitive human speech recordings, the raw audio cannot be deposited in an unrestricted public repository. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.09.29.26364278v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.09.24.26363786v1 "An auditable multimodal agentic system for sequential decision-making across the acute stroke pathway")[Next ](https://www.medrxiv.org/content/10.64898/2026.09.28.26364144v1 "Time-aware machine learning enables early intrapartum identification of fetuses at risk of hypoxic-ischemic encephalopathy from cardiotocography") Posted October 01, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.09.29.26364278v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/10/01/2026.09.29.26364278.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.09.29.26364278v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/10/01/2026.09.29.26364278.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) An explainable multimodal framework for exploring depression-associated speech representations in Alzheimer's disease Hanein Hassan, Dhruv Patel, Hamza Aagela, Anju Johnson medRxiv 2026.09.29.26364278; doi: https://doi.org/10.64898/2026.09.29.26364278 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.29.26364278v1%26text%3DAn%2520explainable%2520multimodal%2520framework%2520for%2520exploring%2520depression-associated%2520speech%2520representations%2520in%2520Alzheimer%2527s%2520disease "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.29.26364278v1%26t%3DAn%2520explainable%2520multimodal%2520framework%2520for%2520exploring%2520depression-associated%2520speech%2520representations%2520in%2520Alzheimer%2527s%2520disease "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.29.26364278v1%26title%3DAn%2520explainable%2520multimodal%2520framework%2520for%2520exploring%2520depression-associated%2520speech%2520representations%2520in%2520Alzheimer%2527s%2520disease%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.09.29.26364278v1%26title%3DAn%2520explainable%2520multimodal%2520framework%2520for%2520exploring%2520depression-associated%2520speech%2520representations%2520in%2520Alzheimer%2527s%2520disease "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.09.29.26364278) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.09.29.26364278v1&count=horizontal&via=&text=An%20explainable%20multimodal%20framework%20for%20exploring%20depression-associated%20speech%20representations%20in%20Alzheimer%27s%20disease&counturl=www.medrxiv.org/content/10.64898/2026.09.29.26364278v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (623) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (910) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (339) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4872) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (483) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (420) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (658) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1640) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16043) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (34) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1215) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7115) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (735) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1072) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5104) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1445) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1788) * [Hematology](https://www.medrxiv.org/collection/hematology) (589) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1353) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16347) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1183) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (675) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (156) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (728) * [Neurology](https://www.medrxiv.org/collection/neurology) (7366) * [Nursing](https://www.medrxiv.org/collection/nursing) (370) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1098) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1257) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1009) * [Oncology](https://www.medrxiv.org/collection/oncology) (3647) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1064) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (399) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (459) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (481) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (141) * [Pathology](https://www.medrxiv.org/collection/pathology) (711) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1821) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (740) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (773) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5966) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9819) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2455) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1472) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1255) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (648) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (781) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (586) * [Surgery](https://www.medrxiv.org/collection/surgery) (786) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (107) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (310) * [Urology](https://www.medrxiv.org/collection/urology) (296) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have
## Related Clinical Research

- [Insomnia linked to higher risk of stroke and hospital admission, major review finds](https://medichelpline.com/clinical-feed/medical-news-today-0-major-review-links-insomnia-to-increased-risk-of-hospitalization-and-stroke.md)
- [Pre-diagnostic 1-year prevalence of polypharmacy and PIMcog in Norwegian outpatients with MCI or d](https://medichelpline.com/clinical-feed/plos-one-14-one-year-pre-diagnostic-prevalence-and-associated-factors-of-polypharmacy-and.md)
- [2026 Stroke Rehabilitation Guideline: Start Early and Address Physical, Cognitive, and Mental Heal](https://medichelpline.com/clinical-feed/medical-news-today-0-stroke-rehab-guidelines-emphasize-early-support-for-physical-cognitive-and.md)
- [Bupropion Hydrochloride for Improving Recovery in Acute Ischaemic Stroke: BASE Trial Protocol](https://medichelpline.com/clinical-feed/bmj-open-4-protocol-for-base-a-multicentre-double-blind-randomised-controlled-trial-of.md)
- [PMOS/PCOS and Risk Signals for Alzheimer’s Disease and Dementia: Evidence Review](https://medichelpline.com/clinical-feed/endocrine-news-0-could-pmos-pcos-be-linked-to-alzheimer-s-disease-and-dementia.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.